© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
756160 |
As an accredited 6-Bromo-2(1H)-Quinazolinone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-2(1H)-Quinazolinone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone who’s worked in pharmaceutical research, custom chemical synthesis, or in a laboratory focused on medicinal development knows the value of a high-quality, well-characterized compound. 6-Bromo-2(1H)-Quinazolinone stands out within its chemical family for its reliable purity and consistent molecular structure, both of which matter a great deal when working on reactions where even tiny impurities can send results sideways. For professionals searching for a solid platform to build new molecules or explore novel biological pathways, this compound provides a dependable starting point.
6-Bromo-2(1H)-Quinazolinone belongs to the quinazolinone group of heterocyclic compounds, which means it carries a unique arrangement of atoms allowing for a wide range of chemical modifications. The presence of the bromine atom at the 6-position brings added value. In synthetic organic chemistry, this specific site enables further functionalization, often through cross-coupling reactions. For anyone in the lab looking to tweak the electronic or physical properties of a molecule, this bromine acts as a useful handle, opening routes that aren't easily available in other forms of quinazolinones.
Speaking from experience in medicinal chemistry labs, it's common practice to swap out halogenated precursors like this for other substituents by leveraging established reactions such as Suzuki or Buchwald–Hartwig couplings. This flexibility turns 6-Bromo-2(1H)-Quinazolinone into a kind of molecular toolkit. Instead of facing roadblocks with less reactive or more inert starting materials, chemists can pursue a wider set of possibilities. In real projects, this can mean the difference between a stalled synthesis and a productive research lead.
From a technical angle, this compound’s identification by CAS number and its systematic chemical structure leave little room for ambiguity. High-purity batches, often above 98%, help avoid the headaches that come from side-products or reaction contaminants. In several advanced synthetic projects, one weak link in reagent quality ruins days of work. Labs that care about reproducibility should pay attention to such details.
Solubility matters, too. Many researchers value that this compound behaves predictably in common polar organic solvents. For synthesis, this means less guesswork about whether the compound will dissolve or cause precipitation disasters inside glassware. In my own bench work, issues with solubility often spill over into wasted time and wasted materials, so standards like these make a difference.
6-Bromo-2(1H)-Quinazolinone often steps in to serve as a building block for the generation of more complex molecules—including drug candidates, agrochemical agents, or even specialty materials for analysis. In pharmaceutical development, the ability to derivatize the quinazolinone scaffold allows researchers to rapidly design and make analogues with altered potency or selectivity for a therapeutic target. The bromine atom’s presence expands this reach, giving easy access to chemical spaces that remain out of reach with simple, unsubstituted quinazolinones.
Teams working on kinase inhibitors, for instance, have drawn on the quinazolinone scaffold in designing molecules that bind with high specificity. Adding the bromine group shifts the electronic structure and stacking behavior of the molecule, sometimes increasing the desired biological activity. A well-characterized supply of 6-Bromo-2(1H)-Quinazolinone lets these teams move from design to practical testing much faster, reducing time lost to re-sourcing or repeating steps due to unreliable materials.
Among similar starting materials, halogen substitution has a clear impact not just on reactivity but also on biological compatibility. Some labs reach for chloro- or fluoro-substituted quinazolinones for their own unique effects, but bromine strikes a balance: larger than chlorine, it changes molecular orientation in predictable ways, yet avoids the reactivity issues sometimes seen with iodine. In my projects comparing analogous reaction partners, the difference in yields and purification steps is usually clear. Brominated variants tend to sit in a comfortable zone—not prone to unwanted side reactions, yet reactive enough to serve as reliable stepping stones.
Other alternatives often fall short in terms of versatility. For instance, a methyl group substitution at the same position on the quinazolinone ring often reduces the number of reactions that the compound can undergo. This locks researchers into more limited routes or demands more aggressive—and sometimes harsher—conditions to achieve similar goals. By contrast, the 6-Bromo compound works as a blank canvas in chemical synthesis.
Quality materials have a huge effect on research efficiency and reliability of results. Throughout my work in collaborative drug development and process improvement, projects often run aground because of unpredictable starting reagents. Trusted sources offering consistently high-purity batches build confidence not just for those doing small-scale discoveries but also for bigger process optimization teams. When the plan is to take an idea from milligram to kilogram scale, trust in the sourcing chain becomes non-negotiable.
This reliability also reduces downstream workflow challenges. A clean, predictable synthetic intermediate like 6-Bromo-2(1H)-Quinazolinone translates into fewer chromatographic purifications, greater batch reproducibility, and much lower waste. The net effect? Cost savings, higher morale among synthetic teams who see progress, and a smoother route to publication or commercialization.
Awareness of batch documentation and transparent quality control makes all the difference. Documented batch histories, clear spectral analysis, and verifiable purity data mark out a reputable supply from the rest. In my own lab, conducting parallel experiments with documented and undocumented chemicals often produces striking contrasts in result variability. Experienced researchers know how quickly trust builds around vendors who provide this level of accountability, and project timelines reflect that advantage.
Clear labeling, accessible material safety data, and responsive customer service support not just compliance but also knowledge transfer in research environments. New team members can hit the ground running, and safety officers can more easily keep teams up to standard. It’s the little workflows—unpacking boxes, logging inventory, preparing for audits—where robust support for documentation shows its real-world value.
As expectations for environmental stewardship and lab safety rise, chemists increasingly lean into reagents that allow for safer processes. Some compounds require elaborate precautions, but 6-Bromo-2(1H)-Quinazolinone does not raise substantial new risks compared with similar aromatic bromides. Basic chemical handling—ventilation, gloves, eye protection—covers the bases for most practical synthesis applications.
Working toward greener chemistry means minimizing hazardous waste and enabling milder reaction conditions. Reliable reactivity at moderate temperatures and compatibility with mainstream solvents allow researchers to avoid harsher reagents or extreme lab environments. Speaking from years handling waste streams and managing compliance, using materials with straightforward disposal and well-known safety characteristics keeps work environments healthier and makes regulatory reporting far less painful.
One perennial challenge in labs is the unexpected failure of key synthetic steps. Much of the time, problems trace back to impurities or subtle batch differences. 6-Bromo-2(1H)-Quinazolinone’s tight quality control and traceable documentation remove one layer of uncertainty. Sourcing from suppliers who actively communicate batch changes and provide technical support helps research teams troubleshoot. Real collaboration with material providers—open lines, rapid response to quality queries, and regular updates—makes a visible difference.
Every synthetic chemist remembers the frustration of reactions that inexplicably fizzle. By eliminating variables in the quality of the building blocks, projects move forward more predictably. In one case, switching to a more traceable source for this compound cut weeks off a multi-step route, letting our team focus attention on truly innovative steps rather than spinning wheels over old ones.
In the path from ideas on paper to scaled-up production, each link in the chain takes trust and clear communication. As a researcher who has lived through scale-up headaches, I can attest that every unexpected impurity, every change in melting point, each surprise peak on a chromatogram can multiply delays. 6-Bromo-2(1H)-Quinazolinone’s value becomes obvious in this context: fewer surprises as projects transition from bench to pilot plant.
On larger scales, waste minimization, reproducibility, and process safety only become more important. This compound, used as an intermediate for targeted drug discovery or in advanced material design, offers straightforward handling properties and makes batch documentation easier to manage. In one production campaign, the ready access to full certificates of analysis and transparent spectroscopic data meant process engineers could trace back every deviation and quickly implement solutions.
Though medicinal chemistry sits at the center of this product’s applications, material scientists, agrochemical developers, and biologists find compelling reasons to use 6-Bromo-2(1H)-Quinazolinone. Its core skeleton underpins specialized fluorescent markers, enzyme inhibitors, and structures for molecular imaging. The modular ease with which the bromine group can be replaced or augmented means even outside the medical field, researchers find novel uses for this compound.
In agricultural chemistry, quinazolinone derivatives serve as templates for new herbicidal or regulatory compounds. Here, the ability to swap the bromine for tailored side chains lets scientists attack problems like resistance or persistent environmental toxicity more creatively. My contacts in agrochemical startups often point out that starting with such versatile intermediates helps compress development timelines and gives them a technical edge.
Emerging synthetic methodologies like photoredox catalysis, electrochemical transformations, and metal-free functionalizations have broadened the way researchers approach compound libraries. 6-Bromo-2(1H)-Quinazolinone fits these newer strategies well. For labs investing in high-throughput experimentation or advanced catalyst screening, this compound adapts to changing workflows.
In practice, this versatility turns complex design challenges into more manageable projects. Researchers save weeks on planning when their starting material works with both established and state-of-the-art synthesis protocols. I’ve witnessed high schoolers and postdocs alike finding success early in their research careers by choosing simple, robust starting materials such as this one. It takes some frustration out of discovery.
Constant conversations between sourcing scientists, bench chemists, and analytical specialists drive better products and improved reliability. My own involvement in user feedback sessions with chemical providers revealed how information from the end-user sharpens the quality and traceability of intermediates like 6-Bromo-2(1H)-Quinazolinone. Meaningful feedback leads to refined packaging sizes, improved labeling, and smarter documentation—a real-world improvement in how science gets done.
One small example: In one synthesis-intensive project, researchers flagged issues with caking in storage at elevated humidity. Responsive suppliers implemented improved moisture barriers. Word quickly rippled out across colleagues, and other teams benefited as well. It’s in these iterative back-and-forth conversations that product quality, safety, and user satisfaction rise above baseline standards.
As science tackles new health, materials, and sustainability challenges, demand for versatile, reliable intermediates remains strong. 6-Bromo-2(1H)-Quinazolinone’s adaptability has solidified its place in well-equipped labs. Looking forward, researchers seeking to build smart molecular libraries or design green, less wasteful processes will come to favor intermediates with the right combination of quality, transparency, and safety.
Broader adoption comes from proven track records. As colleagues trade success stories and share data in conferences or open-access platforms, trust moves from anecdote to standard practice. Labs unfamiliar with the compound soon adopt it as a go-to for building novel compounds or troubleshooting difficult routes. This kind of positive pressure helps raise the bar for all chemical suppliers.
In a world where innovation and rigor go hand in hand, the practical advantages offered by 6-Bromo-2(1H)-Quinazolinone reflect a broader truth about chemical research: Materials matter more than marketing. Consistency, documented purity, and forward-looking chemistry open doors to discoveries that seem out of reach with less reliable building blocks. As someone who has worked both at the bench and at the interface with suppliers, I can vouch for the value of compounds that do exactly what they promise.
Labs ready to take on big questions—whether it’s new therapeutics, sustainable materials, or smarter agrochemicals—need more than theories and wishful thinking. They thrive on dependable resources that stand up to scrutiny. With its flexibility, traceability, and solid support for both legacy and modern synthetic methods, 6-Bromo-2(1H)-Quinazolinone has earned its place as a core reagent in ambitious, results-driven research environments.
